Related Experiment Videos
Oligodendrogliomas: a clinical, histological, immunocytochemical and lectin-binding study
F F Cruz-Sanchez1, M L Rossi, J R Buller
1Neurological Tissue Bank, Hospital Clinico I Provincial, University of Barcelona, Spain.
Histopathology
|October 11, 1991
Summary
This study investigated oligodendrogliomas using antibodies and lectins, revealing changes in cell-associated proteins during malignant transformation and differentiation. These findings highlight altered lectin expression patterns in tumor progression.
Area of Science:
- Neuro-oncology
- Molecular Pathology
- Glycobiology
Background:
- Oligodendrogliomas are primary brain tumors with varying grades of malignancy.
- Understanding molecular markers is crucial for diagnosis and prognosis.
- Glycoprotein expression may play a role in tumor behavior.
Purpose of the Study:
- To investigate the expression of specific proteins and glycoproteins in oligodendrogliomas.
- To correlate marker expression with tumor differentiation and grade.
- To explore the role of lectin binding in malignant transformation.
Main Methods:
- Immunohistochemical analysis of 27 oligodendrogliomas.
- Use of antibodies against vimentin, GFAP, S-100 protein, MBP, and CAM 5.2.
- Assessment of lectin binding (WGA, Con A, PNA, RCA, DBA, SBA) to glycoproteins.
Main Results:
- Vimentin positivity was observed in four tumors, predominantly anaplastic.
- S-100 protein and GFAP showed variable expression across differentiation grades.
- Significant differences in lectin binding patterns (WGA, Con A, PNA, RCA) were noted between well-differentiated and anaplastic oligodendrogliomas.
Conclusions:
- Changes in lectin-like proteins are associated with malignant transformation in oligodendrogliomas.
- Lectin expression patterns evolve during tumor differentiation.
- These findings suggest lectins as potential biomarkers for oligodendroglioma progression.